Favipiravir (Compound)

Synonyms:Favipiravir, 259793-96-9, 6-FLUORO-3-HYDROXYPYRAZINE-2-CARBOXAMIDE, T-705, avigan, 6-fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide, 5-fluoro-2-oxo-1H-pyrazine-3-carboxamide, 6-fluoro-3-hydroxy-2-pyrazinecarboxamide, T 705, Favipiravir (T-705)

Pubchem:PUBCHEM:492405

Id:8b34b923-f2dc-5953-abfb-53387ceaf192

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Favipiravir's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Favipiravir.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Favipiravir.

Results found

Linked to

	Label	Description
	BRD-K04264130-001-01-4 Substance (Entity type)	A Substance
	Favipiravir negatively regulates PTGER4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Favipiravir negatively regulates ABLIM1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Triclabendazole in similarity relationship with Favipiravir Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Favipiravir negatively regulates SPP1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Favipiravir in similarity relationship with C-[3-(2-Dimethylamino-ethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide (Sumatriptan) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Favipiravir positively regulates PUF60 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Favipiravir negatively regulates RGCC Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Favipiravir negatively regulates CEACAM1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Favipiravir positively regulates CYP1B1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

BRD-K04264130-001-01-4

Substance (Entity type)

A Substance

Favipiravir negatively regulates PTGER4

Knowledge Graph Assertion (Entity type)